Biotechnology
The Biotechnology industry has a total of 593 stocks, with a combined market cap of $1.14 trillion and total revenue of $110.26 billion.
Market Cap
1.14T
Revenue
110.26B
Profits
-39.74B
PE Ratio
n/a
Profit Margin
-36.04%
Dividend Yield
0.04%
593 Stocks
| No. | Symbol | Company Name | Market Cap | % Change | Volume | Revenue |
|---|---|---|---|---|---|---|
| 1 | VRTX | Vertex Pharmaceuticals Incorporated | 109.04B | 0.63% | 333,803 | 12.00B |
| 2 | REGN | Regeneron Pharmaceuticals, Inc. | 75.06B | -0.90% | 222,223 | 14.34B |
| 3 | ARGX | argenx SE | 49.41B | -1.87% | 114,162 | 4.24B |
| 4 | ALNY | Alnylam Pharmaceuticals, Inc. | 40.63B | -1.29% | 317,418 | 3.71B |
| 5 | ONC | BeOne Medicines AG | 33.18B | 0.08% | 76,789 | 5.34B |
| 6 | RVMD | Revolution Medicines, Inc. | 30.65B | 10.69% | 3,862,237 | - |
| 7 | RPRX | Royalty Pharma plc | 29.45B | 0.06% | 1,245,506 | 2.38B |
| 8 | INSM | Insmed Incorporated | 28.84B | -1.75% | 666,889 | 606.42M |
| 9 | BNTX | BioNTech SE | 25.57B | -0.91% | 228,090 | 3.37B |
| 10 | ROIV | Roivant Sciences Ltd. | 19.93B | -0.04% | 2,458,498 | 13.31M |
| 11 | INCY | Incyte Corporation | 18.86B | -1.00% | 1,247,187 | 5.36B |
| 12 | MRNA | Moderna, Inc. | 18.74B | -2.98% | 2,163,668 | 1.94B |
| 13 | SMMT | Summit Therapeutics Inc. | 16.68B | -2.85% | 1,487,092 | - |
| 14 | GMAB | Genmab A/S | 16.26B | 0.62% | 1,041,001 | 3.72B |
| 15 | ASND | Ascendis Pharma A/S | 13.77B | -1.68% | 1,516,473 | 845.52M |
| 16 | BBIO | BridgeBio Pharma, Inc. | 13.66B | -5.45% | 9,564,949 | 502.08M |
| 17 | JAZZ | Jazz Pharmaceuticals plc | 12.46B | 0.60% | 238,457 | 4.27B |
| 18 | MDGL | Madrigal Pharmaceuticals, Inc. | 11.87B | -0.51% | 65,815 | 958.40M |
| 19 | IONS | Ionis Pharmaceuticals, Inc. | 11.80B | -1.12% | 851,292 | 943.71M |
| 20 | EXEL | Exelixis, Inc. | 11.42B | 0.67% | 905,521 | 2.32B |
| 21 | BMRN | BioMarin Pharmaceutical Inc. | 10.36B | -0.38% | 304,242 | 3.22B |
| 22 | ARWR | Arrowhead Pharmaceuticals, Inc. | 9.79B | -5.04% | 822,364 | 1.09B |
| 23 | AXSM | Axsome Therapeutics, Inc. | 9.34B | -2.61% | 330,773 | 638.50M |
| 24 | PRAX | Praxis Precision Medicines, Inc. | 8.99B | -2.42% | 238,534 | 7.46M |
| 25 | ABVX | ABIVAX Société Anonyme | 8.98B | -0.86% | 315,786 | 5.37M |
| 26 | PCVX | Vaxcyte, Inc. | 8.49B | -1.26% | 391,026 | - |
| 27 | TECH | Bio-Techne Corporation | 8.39B | -2.72% | 723,808 | 1.22B |
| 28 | NUVL | Nuvalent, Inc. | 8.02B | -1.95% | 158,846 | - |
| 29 | KRYS | Krystal Biotech, Inc. | 7.95B | -0.98% | 73,141 | 389.13M |
| 30 | CYTK | Cytokinetics, Incorporated | 7.69B | 0.47% | 999,651 | 88.04M |
| 31 | HALO | Halozyme Therapeutics, Inc. | 7.45B | -2.54% | 614,930 | 1.40B |
| 32 | IBRX | ImmunityBio, Inc. | 7.26B | -3.57% | 7,345,060 | 113.29M |
| 33 | KYMR | Kymera Therapeutics, Inc. | 6.89B | -2.61% | 200,041 | 39.21M |
| 34 | ACLX | Arcellx, Inc. | 6.75B | - | - | 22.29M |
| 35 | APGE | Apogee Therapeutics, Inc. | 6.32B | -1.03% | 373,649 | - |
| 36 | PTGX | Protagonist Therapeutics, Inc. | 6.28B | -0.02% | 173,328 | 46.02M |
| 37 | BLTE | Belite Bio, Inc | 6.18B | -3.69% | 66,391 | - |
| 38 | TERN | Terns Pharmaceuticals, Inc. | 6.12B | 0.04% | 3,519,150 | - |
| 39 | CNTA | Centessa Pharmaceuticals plc | 6.10B | -0.10% | 668,182 | 15.00M |
| 40 | SYRE | Spyre Therapeutics, Inc. | 6.01B | -3.06% | 350,546 | - |
| 41 | COGT | Cogent Biosciences, Inc. | 5.92B | 0.48% | 662,764 | - |
| 42 | RYTM | Rhythm Pharmaceuticals, Inc. | 5.79B | -0.40% | 131,486 | 189.76M |
| 43 | CELC | Celcuity Inc. | 5.79B | -4.68% | 378,201 | - |
| 44 | MIRM | Mirum Pharmaceuticals, Inc. | 5.74B | 1.72% | 382,076 | 521.31M |
| 45 | CGON | CG Oncology, Inc. | 5.54B | -1.75% | 217,601 | 4.04M |
| 46 | PTCT | PTC Therapeutics, Inc. | 5.53B | -3.61% | 850,144 | 1.73B |
| 47 | IMVT | Immunovant, Inc. | 5.51B | -5.47% | 1,147,150 | - |
| 48 | SRRK | Scholar Rock Holding Corporation | 5.44B | 2.38% | 509,121 | - |
| 49 | CAI | Caris Life Sciences, Inc. | 5.31B | -5.72% | 897,323 | 812.03M |
| 50 | APLS | Apellis Pharmaceuticals, Inc. | 5.24B | - | 1,864,800 | 1.00B |
| 51 | TGTX | TG Therapeutics, Inc. | 5.17B | -0.96% | 838,691 | 616.29M |
| 52 | XENE | Xenon Pharmaceuticals Inc. | 5.11B | -1.22% | 371,502 | 7.50M |
| 53 | CORT | Corcept Therapeutics Incorporated | 5.01B | 0.91% | 299,308 | 761.41M |
| 54 | CRSP | CRISPR Therapeutics AG | 5.00B | 1.84% | 831,057 | 3.51M |
| 55 | LGND | Ligand Pharmaceuticals Incorporated | 4.66B | -3.83% | 86,353 | 268.09M |
| 56 | DNTH | Dianthus Therapeutics, Inc. | 4.60B | -3.02% | 235,960 | 2.04M |
| 57 | FOLD | Amicus Therapeutics, Inc. | 4.55B | 0.21% | 5,285,334 | 634.21M |
| 58 | LEGN | Legend Biotech Corporation | 4.38B | 0.17% | 1,330,624 | 1.03B |
| 59 | CRNX | Crinetics Pharmaceuticals, Inc. | 3.96B | -2.02% | 1,006,006 | 7.70M |
| 60 | VKTX | Viking Therapeutics, Inc. | 3.85B | 0.59% | 891,219 | - |
| 61 | ACAD | ACADIA Pharmaceuticals Inc. | 3.83B | 0.63% | 581,870 | 1.07B |
| 62 | TVTX | Travere Therapeutics, Inc. | 3.80B | 0.81% | 524,332 | 490.73M |
| 63 | ORKA | Oruka Therapeutics, Inc. | 3.79B | -1.14% | 1,667,901 | - |
| 64 | MANE | Veradermics, Incorporated | 3.71B | -0.77% | 586,281 | - |
| 65 | TLX | Telix Pharmaceuticals Limited | 3.59B | 0.29% | 41,943 | 803.79M |
| 66 | TNGX | Tango Therapeutics, Inc. | 3.57B | -5.89% | 1,705,538 | 62.38M |
| 67 | CPRX | Catalyst Pharmaceuticals, Inc. | 3.56B | -0.27% | 1,167,104 | 588.99M |
| 68 | EWTX | Edgewise Therapeutics, Inc. | 3.28B | -0.10% | 1,275,894 | - |
| 69 | NAMS | NewAmsterdam Pharma Company N.V. | 3.25B | -7.03% | 673,969 | 22.50M |
| 70 | GPCR | Structure Therapeutics Inc. | 3.16B | -1.48% | 401,233 | - |
| 71 | DNLI | Denali Therapeutics Inc. | 3.16B | -0.15% | 525,778 | - |
| 72 | RCUS | Arcus Biosciences, Inc. | 3.10B | -1.12% | 973,051 | 247.00M |
| 73 | ERAS | Erasca, Inc. | 3.10B | -47.99% | 39,593,456 | - |
| 74 | BEAM | Beam Therapeutics Inc. | 3.06B | 4.65% | 1,479,392 | 139.74M |
| 75 | ALMS | Alumis Inc. | 3.05B | -3.27% | 658,908 | 24.05M |
| 76 | DYN | Dyne Therapeutics, Inc. | 3.00B | 0.50% | 954,245 | - |
| 77 | KLRA | Kailera Therapeutics, Inc. | 2.88B | -0.89% | 151,334 | - |
| 78 | ARQT | Arcutis Biotherapeutics, Inc. | 2.88B | -1.84% | 472,846 | 376.07M |
| 79 | NKTR | Nektar Therapeutics | 2.83B | -3.28% | 616,155 | 55.23M |
| 80 | KOD | Kodiak Sciences Inc. | 2.78B | 2.24% | 237,289 | - |
| 81 | SLNO | Soleno Therapeutics, Inc. | 2.73B | 0.06% | 633,557 | 190.41M |
| 82 | VERA | Vera Therapeutics, Inc. | 2.68B | 0.35% | 890,697 | - |
| 83 | IMNM | Immunome, Inc. | 2.64B | -0.51% | 235,764 | 6.94M |
| 84 | CLDX | Celldex Therapeutics, Inc. | 2.63B | -0.36% | 359,619 | 1.55M |
| 85 | TARS | Tarsus Pharmaceuticals, Inc. | 2.62B | 1.17% | 240,551 | 451.36M |
| 86 | ELVN | Enliven Therapeutics, Inc. | 2.60B | -3.12% | 279,894 | - |
| 87 | IRON | Disc Medicine, Inc. | 2.59B | -1.37% | 144,380 | - |
| 88 | IDYA | IDEAYA Biosciences, Inc. | 2.56B | -1.15% | 309,684 | 218.71M |
| 89 | ADMA | ADMA Biologics, Inc. | 2.53B | -0.27% | 1,659,143 | 510.17M |
| 90 | ZLAB | Zai Lab Limited | 2.49B | 1.14% | 240,757 | 460.16M |
| 91 | RLAY | Relay Therapeutics, Inc. | 2.48B | -12.37% | 4,062,157 | 15.36M |
| 92 | RARE | Ultragenyx Pharmaceutical Inc. | 2.42B | 2.71% | 685,919 | 673.00M |
| 93 | SRPT | Sarepta Therapeutics, Inc. | 2.21B | 0.29% | 1,198,381 | 2.20B |
| 94 | AAPG | Ascentage Pharma Group International | 2.16B | -1.58% | 3,172 | 82.08M |
| 95 | ADPT | Adaptive Biotechnologies Corporation | 2.16B | -1.41% | 669,209 | 276.98M |
| 96 | TYRA | Tyra Biosciences, Inc. | 2.13B | -3.01% | 278,708 | - |
| 97 | MLYS | Mineralys Therapeutics, Inc. | 2.12B | -4.71% | 626,933 | - |
| 98 | AUPH | Aurinia Pharmaceuticals Inc. | 2.10B | -1.41% | 428,549 | 283.06M |
| 99 | DFTX | Definium Therapeutics, Inc. | 2.09B | 0.05% | 675,503 | - |
| 100 | ZYME | Zymeworks Inc. | 2.07B | -1.51% | 160,501 | 105.97M |
| 101 | OCUL | Ocular Therapeutix, Inc. | 2.01B | -2.89% | 952,050 | 51.95M |
| 102 | MESO | Mesoblast Limited | 2.00B | -1.04% | 50,484 | 65.38M |
| 103 | STOK | Stoke Therapeutics, Inc. | 1.98B | -0.62% | 148,888 | 184.42M |
| 104 | CAPR | Capricor Therapeutics, Inc. | 1.97B | -3.13% | 388,834 | 11.13M |
| 105 | TRVI | Trevi Therapeutics, Inc. | 1.91B | -4.77% | 593,469 | - |
| 106 | INBX | Inhibrx Biosciences, Inc. | 1.90B | -0.92% | 225,511 | 1.30M |
| 107 | ANAB | AnaptysBio, Inc. | 1.90B | -0.92% | 325,017 | 234.60M |
| 108 | GLPG | Galapagos NV | 1.89B | -0.11% | 81,798 | 1.31B |
| 109 | SNDX | Syndax Pharmaceuticals, Inc. | 1.85B | 0.14% | 364,546 | 172.35M |
| 110 | PHVS | Pharvaris N.V. | 1.85B | -1.64% | 102,439 | - |
| 111 | RXRX | Recursion Pharmaceuticals, Inc. | 1.82B | -0.86% | 5,127,325 | 74.68M |
| 112 | PVLA | Palvella Therapeutics, Inc. | 1.82B | -1.21% | 194,547 | - |
| 113 | VCEL | Vericel Corporation | 1.81B | -3.70% | 253,535 | 276.26M |
| 114 | TSHA | Taysha Gene Therapies, Inc. | 1.79B | -3.56% | 1,008,789 | 9.77M |
| 115 | SION | Sionna Therapeutics, Inc. | 1.79B | 0.97% | 192,625 | - |
| 116 | NRIX | Nurix Therapeutics, Inc. | 1.79B | 4.79% | 576,136 | 71.78M |
| 117 | HRMY | Harmony Biosciences Holdings, Inc. | 1.79B | -0.61% | 249,937 | 868.45M |
| 118 | INVA | Innoviva, Inc. | 1.75B | 0.88% | 257,686 | 411.33M |
| 119 | VIR | Vir Biotechnology, Inc. | 1.65B | -3.95% | 849,188 | 68.56M |
| 120 | NBTX | Nanobiotix S.A. | 1.61B | -0.39% | 128,896 | 38.27M |
| 121 | RAPP | Rapport Therapeutics, Inc. | 1.61B | -4.86% | 106,075 | - |
| 122 | GENB | Generate Biomedicines, Inc. | 1.59B | 0.24% | 135,236 | 31.89M |
| 123 | OCS | Oculis Holding AG | 1.58B | -1.29% | 110,903 | 1.51M |
| 124 | NUVB | Nuvation Bio Inc. | 1.58B | -0.55% | 2,728,890 | 62.90M |
| 125 | NTLA | Intellia Therapeutics, Inc. | 1.57B | 1.69% | 7,996,273 | 67.67M |
| 126 | ATAI | AtaiBeckley Inc. | 1.54B | -2.53% | 2,166,245 | 4.09M |
| 127 | IMTX | Immatics N.V. | 1.54B | 1.32% | 108,968 | 56.67M |
| 128 | GLUE | Monte Rosa Therapeutics, Inc. | 1.51B | -2.18% | 301,251 | 123.67M |
| 129 | ARDX | Ardelyx, Inc. | 1.48B | 0.58% | 807,952 | 407.32M |
| 130 | IMCR | Immunocore Holdings plc | 1.47B | 1.52% | 141,354 | 400.02M |
| 131 | DMRA | Damora Therapeutics, Inc. | 1.47B | -4.43% | 56,138 | - |
| 132 | AGIO | Agios Pharmaceuticals, Inc. | 1.45B | 0.98% | 275,558 | 54.03M |
| 133 | BHVN | Biohaven Ltd. | 1.44B | - | 639,711 | - |
| 134 | BCAX | Bicara Therapeutics Inc. | 1.44B | -2.31% | 82,179 | - |
| 135 | MBX | MBX Biosciences, Inc. | 1.43B | -5.82% | 503,523 | - |
| 136 | MAZE | Maze Therapeutics, Inc. | 1.42B | -2.98% | 426,397 | 2.50M |
| 137 | WVE | Wave Life Sciences Ltd. | 1.41B | 5.76% | 2,959,927 | 71.80M |
| 138 | PGEN | Precigen, Inc. | 1.41B | 0.63% | 850,082 | 9.68M |
| 139 | IOVA | Iovance Biotherapeutics, Inc. | 1.39B | -1.46% | 7,344,356 | 263.50M |
| 140 | VRDN | Viridian Therapeutics, Inc. | 1.38B | -0.48% | 1,967,925 | 70.85M |
| 141 | MPLT | MapLight Therapeutics, Inc. | 1.33B | -1.21% | 100,487 | - |
| 142 | JBIO | Jade Biosciences, Inc. | 1.32B | -0.22% | 317,023 | - |
| 143 | OLMA | Olema Pharmaceuticals, Inc. | 1.30B | -2.16% | 385,539 | - |
| 144 | CRVS | Corvus Pharmaceuticals, Inc. | 1.30B | -2.58% | 428,189 | - |
| 145 | AVBP | ArriVent BioPharma, Inc. | 1.30B | -2.93% | 251,705 | - |
| 146 | NVAX | Novavax, Inc. | 1.30B | -1.05% | 2,014,082 | 1.12B |
| 147 | SVRA | Savara Inc. | 1.28B | -2.03% | 352,005 | - |
| 148 | ABCL | AbCellera Biologics Inc. | 1.27B | 1.08% | 8,356,832 | 75.13M |
| 149 | DBVT | DBV Technologies S.A. | 1.22B | 2.18% | 100,340 | 5.64M |
| 150 | MLTX | MoonLake Immunotherapeutics | 1.21B | -0.09% | 178,248 | - |
| 151 | GHRS | GH Research PLC | 1.20B | -1.25% | 106,975 | - |
| 152 | URGN | UroGen Pharma Ltd. | 1.18B | 2.31% | 224,111 | 109.79M |
| 153 | PHAR | Pharming Group N.V. | 1.18B | -2.75% | 1,054 | 376.13M |
| 154 | QURE | uniQure N.V. | 1.14B | 0.61% | 512,591 | 16.10M |
| 155 | EYPT | EyePoint, Inc. | 1.12B | -1.69% | 184,718 | 31.37M |
| 156 | SEPN | Septerna, Inc. | 1.08B | -4.20% | 107,171 | 45.95M |
| 157 | ZBIO | Zenas BioPharma, Inc. | 1.06B | -4.20% | 216,609 | 10.00M |
| 158 | AKTS | Aktis Oncology, Inc. | 1.05B | -5.57% | 145,928 | 6.50M |
| 159 | IVA | Inventiva S.A. | 1.05B | -1.75% | 59,013 | 7.94M |
| 160 | OMER | Omeros Corporation | 1.05B | -1.49% | 1,116,839 | - |
| 161 | XERS | Xeris Biopharma Holdings, Inc. | 1.04B | -1.31% | 505,413 | 291.85M |
| 162 | FTRE | Fortrea Holdings Inc. | 1.01B | 1.42% | 776,737 | 2.72B |
| 163 | KALV | KalVista Pharmaceuticals, Inc. | 975.79M | -0.57% | 394,558 | 73.62M |
| 164 | ANNX | Annexon, Inc. | 971.79M | -1.97% | 1,241,496 | - |
| 165 | GERN | Geron Corporation | 970.96M | -0.98% | 6,814,311 | 183.88M |
| 166 | ORIC | ORIC Pharmaceuticals, Inc. | 956.41M | -6.48% | 562,484 | - |
| 167 | MRVI | Maravai LifeSciences Holdings, Inc. | 915.16M | -3.26% | 386,898 | 185.74M |
| 168 | SANA | Sana Biotechnology, Inc. | 909.55M | 1.69% | 994,766 | - |
| 169 | CTMX | CytomX Therapeutics, Inc. | 907.78M | -2.80% | 1,828,377 | 76.20M |
| 170 | EVMN | Evommune, Inc. | 905.86M | 0.60% | 102,683 | 13.00M |
| 171 | XNCR | Xencor, Inc. | 896.93M | -6.64% | 395,946 | 125.58M |
| 172 | PHAT | Phathom Pharmaceuticals, Inc. | 895.97M | -2.67% | 935,294 | 175.11M |
| 173 | LBRX | LB Pharmaceuticals Inc | 894.68M | -1.92% | 62,648 | - |
| 174 | JANX | Janux Therapeutics, Inc. | 882.06M | -4.79% | 565,573 | 10.00M |
| 175 | SLS | SELLAS Life Sciences Group, Inc. | 876.36M | - | 2,344,461 | - |
| 176 | DRUG | Bright Minds Biosciences Inc. | 873.45M | -0.72% | 44,459 | - |
| 177 | MNKD | MannKind Corporation | 861.54M | 6.08% | 3,621,391 | 348.97M |
| 178 | MGTX | MeiraGTx Holdings plc | 860.78M | 1.86% | 248,974 | 81.39M |
| 179 | TBPH | Theravance Biopharma, Inc. | 856.84M | -1.01% | 139,898 | 107.46M |
| 180 | TENX | Tenax Therapeutics, Inc. | 846.67M | -4.83% | 688,481 | - |
| 181 | ANRO | Alto Neuroscience, Inc. | 845.82M | -0.58% | 65,163 | - |
| 182 | ABUS | Arbutus Biopharma Corporation | 813.36M | -3.50% | 431,153 | 14.08M |
| 183 | CBIO | Crescent Biopharma, Inc. | 807.47M | -3.38% | 30,180 | 10.84M |
| 184 | DSGN | Design Therapeutics, Inc. | 791.26M | 0.16% | 91,035 | - |
| 185 | SPRY | ARS Pharmaceuticals, Inc. | 790.41M | 0.13% | 653,418 | 84.28M |
| 186 | KURA | Kura Oncology, Inc. | 788.21M | -2.09% | 476,080 | 67.48M |
| 187 | VOR | Vor Biopharma Inc. | 779.19M | 1.84% | 245,289 | - |
| 188 | CGEM | Cullinan Therapeutics, Inc. | 773.52M | -3.55% | 227,577 | - |
| 189 | SGP | SpyGlass Pharma, Inc. | 772.82M | -2.24% | 10,954 | - |
| 190 | ALLO | Allogene Therapeutics, Inc. | 761.91M | -1.56% | 3,390,166 | 22.00K |
| 191 | ABSI | Absci Corporation | 760.52M | 2.47% | 4,130,766 | 2.80M |
| 192 | RLMD | Relmada Therapeutics, Inc. | 753.10M | 2.13% | 543,791 | - |
| 193 | SLDB | Solid Biosciences Inc. | 730.09M | -1.07% | 355,760 | - |
| 194 | BBOT | BridgeBio Oncology Therapeutics, Inc. | 708.29M | 0.68% | 355,070 | - |
| 195 | LXRX | Lexicon Pharmaceuticals, Inc. | 707.55M | -1.18% | 673,102 | 49.80M |
| 196 | TRAX | First Tracks Biotherapeutics, Inc. | 704.71M | 12.04% | 291,139 | - |
| 197 | GYRE | Gyre Therapeutics, Inc. | 699.47M | 0.39% | 28,742 | 116.59M |
| 198 | ARVN | Arvinas, Inc. | 657.52M | -0.10% | 173,879 | 262.60M |
| 199 | FBRX | Forte Biosciences, Inc. | 656.26M | 0.04% | 178,189 | - |
| 200 | PRME | Prime Medicine, Inc. | 655.19M | 0.82% | 1,059,589 | 4.63M |
| 201 | DRTS | Alpha Tau Medical Ltd. | 650.39M | -6.57% | 383,790 | - |
| 202 | PRTA | Prothena Corporation plc | 615.85M | 6.02% | 209,733 | 9.68M |
| 203 | CRMD | CorMedix Inc. | 596.05M | -2.81% | 681,294 | 311.71M |
| 204 | STRO | Sutro Biopharma, Inc. | 592.44M | 6.46% | 130,299 | 102.48M |
| 205 | ACRS | Aclaris Therapeutics, Inc. | 592.12M | -3.40% | 946,608 | 7.83M |
| 206 | ZVRA | Zevra Therapeutics, Inc. | 584.65M | 0.82% | 283,785 | 106.47M |
| 207 | RIGL | Rigel Pharmaceuticals, Inc. | 567.80M | 0.70% | 130,363 | 294.28M |
| 208 | STTK | Shattuck Labs, Inc. | 566.11M | -2.98% | 187,456 | 1.00M |
| 209 | OCGN | Ocugen, Inc. | 565.32M | -1.76% | 3,132,858 | 4.41M |
| 210 | PROK | ProKidney Corp. | 558.63M | -0.54% | 167,629 | 893.00K |
| 211 | ALT | Altimmune, Inc. | 535.99M | -1.43% | 2,405,263 | 41.00K |
| 212 | KYTX | Kyverna Therapeutics, Inc. | 529.64M | -2.67% | 464,172 | - |
| 213 | TECX | Tectonic Therapeutic, Inc. | 517.67M | -4.10% | 65,404 | - |
| 214 | AGMB | AgomAb Therapeutics NV | 512.71M | -7.07% | 78,343 | - |
| 215 | UPB | Upstream Bio, Inc. | 508.28M | 0.54% | 214,884 | 2.85M |
| 216 | LYEL | Lyell Immunopharma, Inc. | 505.06M | -4.29% | 35,786 | 36.00K |
| 217 | ZURA | Zura Bio Limited | 504.77M | -1.66% | 179,322 | - |
| 218 | MDXG | MiMedx Group, Inc. | 503.64M | 1.50% | 579,015 | 418.63M |
| 219 | FULC | Fulcrum Therapeutics, Inc. | 498.42M | -3.11% | 356,848 | 80.00M |
| 220 | XOMA | XOMA Royalty Corporation | 489.74M | -2.07% | 359,819 | 52.15M |
| 221 | VALN | Valneva SE | 485.14M | 0.73% | 26,164 | 205.07M |
| 222 | FDMT | 4D Molecular Therapeutics, Inc. | 483.46M | 0.21% | 179,638 | 85.21M |
| 223 | ADCT | ADC Therapeutics SA | 480.78M | 0.53% | 358,854 | 81.36M |
| 224 | VSTM | Verastem, Inc. | 476.99M | -1.99% | 1,071,705 | 30.91M |
| 225 | ENGN | enGene Therapeutics Inc. | 468.26M | -2.92% | 1,564,868 | - |
| 226 | IMMX | Immix Biopharma, Inc. | 467.57M | -7.45% | 341,971 | - |
| 227 | OVID | Ovid Therapeutics Inc. | 467.20M | 0.37% | 894,556 | 7.25M |
| 228 | TRDA | Entrada Therapeutics, Inc. | 460.44M | -1.31% | 66,797 | 25.42M |
| 229 | CTNM | Contineum Therapeutics, Inc. | 458.49M | -5.32% | 56,571 | - |
| 230 | ANL | Adlai Nortye Ltd. | 454.40M | -14.26% | 878,116 | 5.00M |
| 231 | DNA | Ginkgo Bioworks Holdings, Inc. | 454.02M | -0.26% | 215,699 | 170.16M |
| 232 | EIKN | Eikon Therapeutics, Inc. | 452.60M | -4.35% | 157,098 | - |
| 233 | LRMR | Larimar Therapeutics, Inc. | 450.85M | -2.25% | 852,463 | - |
| 234 | CADL | Candel Therapeutics, Inc. | 450.47M | -2.23% | 362,302 | - |
| 235 | CLYM | Climb Bio, Inc. | 448.55M | -1.16% | 2,204,444 | - |
| 236 | RGNX | REGENXBIO Inc. | 446.75M | 0.41% | 229,014 | 170.44M |
| 237 | EPRX | Eupraxia Pharmaceuticals Inc. | 445.74M | -1.94% | 142,687 | - |
| 238 | AVIR | Atea Pharmaceuticals, Inc. | 441.38M | 3.36% | 150,842 | - |
| 239 | AURA | Aura Biosciences, Inc. | 440.41M | -1.44% | 51,470 | - |
| 240 | NGNE | Neurogene Inc. | 431.93M | 2.26% | 69,520 | 925.00K |
| 241 | ASMB | Assembly Biosciences, Inc. | 428.13M | -1.93% | 28,294 | 72.30M |
| 242 | PRTC | PureTech Health plc | 427.41M | 2.02% | 12,443 | 6.39M |
| 243 | PRLD | Prelude Therapeutics Incorporated | 426.34M | -6.19% | 237,132 | 12.14M |
| 244 | LXEO | Lexeo Therapeutics, Inc. | 423.41M | 1.60% | 171,871 | - |
| 245 | BNTC | Benitec Biopharma Inc. | 422.71M | -2.14% | 36,812 | - |
| 246 | VNDA | Vanda Pharmaceuticals Inc. | 400.75M | -0.15% | 561,061 | 216.11M |
| 247 | ENTA | Enanta Pharmaceuticals, Inc. | 398.44M | 3.39% | 44,284 | 66.98M |
| 248 | NMRA | Neumora Therapeutics, Inc. | 398.26M | -1.80% | 420,283 | - |
| 249 | IPSC | Century Therapeutics, Inc. | 397.93M | -1.78% | 235,700 | 109.16M |
| 250 | IVVD | Invivyd, Inc. | 395.93M | -4.11% | 644,349 | 53.43M |
| 251 | AUTL | Autolus Therapeutics plc | 393.89M | 4.23% | 1,054,327 | 75.39M |
| 252 | LCTX | Lineage Cell Therapeutics, Inc. | 392.31M | 1.61% | 768,297 | 14.56M |
| 253 | NAGE | Niagen Bioscience, Inc. | 391.61M | -1.61% | 385,787 | 129.42M |
| 254 | PBYI | Puma Biotechnology, Inc. | 381.57M | -0.13% | 125,325 | 228.37M |
| 255 | VTVT | vTv Therapeutics Inc. | 380.97M | 4.42% | 82,740 | 17.00K |
| 256 | XFOR | X4 Pharmaceuticals, Inc. | 376.33M | -1.68% | 136,629 | 35.11M |
| 257 | RCKT | Rocket Pharmaceuticals, Inc. | 374.29M | -1.72% | 2,374,792 | - |
| 258 | YDES | YD Bio Limited | 369.18M | -3.85% | 14,466 | 510.36K |
| 259 | SLN | Silence Therapeutics plc | 366.06M | -0.90% | 161,902 | 559.00K |
| 260 | AVTX | Avalo Therapeutics, Inc. | 365.99M | -4.99% | 394,937 | 59.00K |
| 261 | MNPR | Monopar Therapeutics Inc. | 360.67M | -0.23% | 39,451 | - |
| 262 | ARMP | Armata Pharmaceuticals, Inc. | 356.07M | -11.64% | 83,443 | 4.90M |
| 263 | IRD | Opus Genetics, Inc. | 354.87M | -2.93% | 922,320 | 14.20M |
| 264 | SRZN | Surrozen, Inc. | 349.66M | 1.64% | 43,841 | 3.48M |
| 265 | IMRX | Immuneering Corporation | 346.13M | -7.12% | 580,065 | - |
| 266 | DMAC | DiaMedica Therapeutics Inc. | 337.84M | -0.79% | 49,725 | - |
| 267 | PALI | Palisade Bio, Inc. | 333.17M | 1.53% | 2,152,009 | - |
| 268 | CMPX | Compass Therapeutics, Inc. | 331.36M | 2.79% | 27,567,923 | 850.00K |
| 269 | NAUT | Nautilus Biotechnology, Inc. | 329.07M | 1.17% | 280,429 | - |
| 270 | BCYC | Bicycle Therapeutics plc | 327.62M | -1.47% | 186,307 | 72.59M |
| 271 | GLSI | Greenwich LifeSciences, Inc. | 319.97M | -3.73% | 44,800 | - |
| 272 | IKT | Inhibikase Therapeutics, Inc. | 318.75M | -1.06% | 330,584 | 1.00 |
| 273 | RZLT | Rezolute, Inc. | 317.33M | -7.70% | 858,994 | - |
| 274 | CABA | Cabaletta Bio, Inc. | 315.04M | -2.75% | 2,162,958 | - |
| 275 | NGEN | NervGen Pharma Corp. | 313.20M | 0.52% | 92,402 | - |
| 276 | AVXL | Anavex Life Sciences Corp. | 311.38M | 2.13% | 328,716 | - |
| 277 | ABEO | Abeona Therapeutics Inc. | 304.32M | 0.19% | 174,834 | 5.82M |
| 278 | FHTX | Foghorn Therapeutics Inc. | 302.31M | -1.15% | 71,946 | 30.91M |
| 279 | EDIT | Editas Medicine, Inc. | 298.51M | 5.54% | 701,679 | 40.52M |
| 280 | ACIU | AC Immune SA | 296.61M | 5.28% | 222,588 | 4.51M |
| 281 | LENZ | LENZ Therapeutics, Inc. | 294.42M | -3.79% | 435,630 | 19.09M |
| 282 | ZNTL | Zentalis Pharmaceuticals, Inc. | 293.65M | -2.59% | 793,314 | 26.87M |
| 283 | CLLS | Cellectis S.A. | 291.55M | -2.24% | 3,988 | 79.59M |
| 284 | SGMT | Sagimet Biosciences Inc. | 282.19M | 6.65% | 2,300,404 | - |
| 285 | NERV | Minerva Neurosciences, Inc. | 279.93M | -0.70% | 66,028 | - |
| 286 | NBP | NovaBridge Biosciences | 278.71M | -0.82% | 119,166 | - |
| 287 | CHRS | Coherus Oncology, Inc. | 273.74M | -3.53% | 415,899 | 42.17M |
| 288 | CCCC | C4 Therapeutics, Inc. | 272.73M | -1.24% | 976,401 | 35.95M |
| 289 | TARA | Protara Therapeutics, Inc. | 270.42M | 0.20% | 227,802 | - |
| 290 | ELDN | Eledon Pharmaceuticals, Inc. | 267.78M | 1.88% | 641,410 | - |
| 291 | HELP | Cybin Inc. | 263.69M | -2.41% | 674,812 | - |
| 292 | ALEC | Alector, Inc. | 261.56M | 0.85% | 163,221 | 21.05M |
| 293 | PLYX | Polaryx Therapeutics, Inc. | 256.60M | 6.90% | 28,022 | - |
| 294 | CGEN | Compugen Ltd. | 252.93M | -8.39% | 573,295 | 72.76M |
| 295 | ARCT | Arcturus Therapeutics Holdings Inc. | 251.54M | 6.63% | 247,485 | 82.03M |
| 296 | SABS | SAB Biotherapeutics, Inc. | 245.96M | 0.86% | 141,998 | 114.70K |
| 297 | CDXS | Codexis, Inc. | 245.80M | 2.08% | 696,469 | 70.39M |
| 298 | FENC | Fennec Pharmaceuticals Inc. | 235.47M | -0.29% | 20,465 | 44.64M |
| 299 | NVCT | Nuvectis Pharma, Inc. | 230.48M | -0.57% | 20,473 | - |
| 300 | HRTX | Heron Therapeutics, Inc. | 229.20M | 2.10% | 1,514,437 | 154.90M |
| 301 | ARTV | Artiva Biotherapeutics, Inc. | 229.12M | -13.77% | 155,724 | 251.00K |
| 302 | OBIO | Orchestra BioMed Holdings, Inc. | 228.82M | -4.63% | 122,586 | 33.48M |
| 303 | SLGL | Sol-Gel Technologies Ltd. | 228.80M | -9.10% | 24,273 | 19.39M |
| 304 | MIST | Milestone Pharmaceuticals Inc. | 228.74M | 0.27% | 407,697 | 1.55M |
| 305 | CAMP | Camp4 Therapeutics Corporation | 226.89M | -1.58% | 18,780 | 3.50M |
| 306 | ADAG | Adagene Inc. | 226.63M | -3.65% | 120,071 | 7.67M |
| 307 | KROS | Keros Therapeutics, Inc. | 224.78M | 3.54% | 142,884 | 244.06M |
| 308 | VYGR | Voyager Therapeutics, Inc. | 222.60M | -0.66% | 138,861 | 40.37M |
| 309 | ACHV | Achieve Life Sciences, Inc. | 220.95M | 4.80% | 821,335 | - |
| 310 | CNTX | Context Therapeutics Inc. | 216.83M | 0.85% | 511,199 | - |
| 311 | REPL | Replimune Group, Inc. | 216.75M | -2.05% | 3,020,316 | - |
| 312 | ALXO | ALX Oncology Holdings Inc. | 213.95M | - | 440,873 | - |
| 313 | MDWD | MediWound Ltd. | 211.42M | -0.72% | 16,372 | 16.96M |
| 314 | ENLV | Enlivex Ltd. | 209.98M | 0.26% | 168,072 | - |
| 315 | OKUR | OnKure Therapeutics, Inc. | 208.84M | 3.61% | 69,701 | - |
| 316 | OABI | OmniAb, Inc. | 203.42M | -2.43% | 222,527 | 18.67M |
| 317 | WHWK | Whitehawk Therapeutics, Inc. | 200.59M | 2.16% | 96,640 | 7.15M |
| 318 | CRBU | Caribou Biosciences, Inc. | 200.52M | -2.58% | 586,567 | 11.16M |
| 319 | ELTX | Elicio Therapeutics, Inc. | 199.78M | -4.40% | 75,323 | - |
| 320 | NKTX | Nkarta, Inc. | 198.90M | -1.41% | 257,401 | - |
| 321 | CNTN | Canton Strategic Holdings, Inc. | 195.18M | 4.08% | 507,857 | - |
| 322 | KPTI | Karyopharm Therapeutics Inc. | 193.87M | -0.69% | 133,169 | 146.07M |
| 323 | MGNX | MacroGenics, Inc. | 190.36M | -1.80% | 265,066 | 149.50M |
| 324 | KRRO | Korro Bio, Inc. | 184.75M | -0.23% | 21,971 | 6.39M |
| 325 | RNAC | Cartesian Therapeutics, Inc. | 183.31M | -2.47% | 58,780 | 2.80M |
| 326 | DTIL | Precision BioSciences, Inc. | 181.91M | 0.14% | 51,807 | 34.26M |
| 327 | TNXP | Tonix Pharmaceuticals Holding Corp. | 181.83M | -0.31% | 153,229 | 13.11M |
| 328 | UNCY | Unicycive Therapeutics, Inc. | 180.70M | -0.97% | 163,687 | - |
| 329 | ABOS | Acumen Pharmaceuticals, Inc. | 179.81M | -1.19% | 126,078 | - |
| 330 | HUMA | Humacyte, Inc. | 177.42M | -0.84% | 3,207,497 | 2.04M |
| 331 | ANTX | AN2 Therapeutics, Inc. | 175.30M | 1.46% | 130,934 | - |
| 332 | CRBP | Corbus Pharmaceuticals Holdings, Inc. | 174.88M | -2.18% | 107,778 | - |
| 333 | PLX | Protalix BioTherapeutics, Inc. | 170.81M | -1.85% | 227,742 | 52.74M |
| 334 | MENS | Jyong Biotech Ltd. | 166.87M | 0.93% | 42,541 | - |
| 335 | ORMP | Oramed Pharmaceuticals Inc. | 162.59M | -2.19% | 158,611 | 2.00M |
| 336 | MOLN | Molecular Partners AG | 159.72M | 0.69% | 714 | 856.30K |
| 337 | TLSA | Tiziana Life Sciences Ltd | 155.70M | -3.17% | 160,316 | - |
| 338 | BDTX | Black Diamond Therapeutics, Inc. | 155.54M | -7.02% | 436,442 | 70.00M |
| 339 | SPRO | Spero Therapeutics, Inc. | 155.15M | 0.37% | 130,234 | 66.80M |
| 340 | PRQR | ProQR Therapeutics N.V. | 153.83M | -2.01% | 734,298 | 19.19M |
| 341 | ALPS | Alps Group Inc | 153.27M | 0.12% | 3,811 | 3.74M |
| 342 | AGEN | Agenus Inc. | 152.25M | -3.06% | 473,004 | 114.20M |
| 343 | GALT | Galectin Therapeutics Inc. | 152.06M | -2.53% | 82,014 | - |
| 344 | FATE | Fate Therapeutics, Inc. | 151.14M | -0.76% | 490,629 | 6.65M |
| 345 | TNYA | Tenaya Therapeutics, Inc. | 150.40M | -0.99% | 1,989,363 | - |
| 346 | SPRB | Spruce Biosciences, Inc. | 147.52M | -4.53% | 29,068 | 697.00K |
| 347 | KZIA | Kazia Therapeutics Limited | 140.89M | 3.18% | 151,725 | 1.27M |
| 348 | IMUX | Immunic, Inc. | 137.12M | 5.31% | 270,675 | - |
| 349 | HURA | TuHURA Biosciences, Inc. | 134.47M | -4.73% | 610,729 | - |
| 350 | CNTB | Connect Biopharma Holdings Limited | 132.83M | -4.08% | 116,101 | 64.00K |
| 351 | ACOG | Alpha Cognition Inc. | 131.52M | -6.07% | 71,715 | 10.22M |
| 352 | EQ | Equillium, Inc. | 130.25M | 0.98% | 124,043 | 4.39M |
| 353 | KLRS | Kalaris Therapeutics, Inc. | 127.71M | -7.48% | 129,611 | - |
| 354 | IPHA | Innate Pharma S.A. | 127.25M | 0.71% | 10,509 | 10.57M |
| 355 | IFRX | InflaRx N.V. | 125.07M | 7.45% | 3,172,219 | 34.44K |
| 356 | EDSA | Edesa Biotech, Inc. | 122.18M | 23.10% | 3,323,504 | - |
| 357 | AARD | Aardvark Therapeutics, Inc. | 118.46M | -1.63% | 59,768 | - |
| 358 | BMEA | Biomea Fusion, Inc. | 116.04M | -7.23% | 1,538,022 | - |
| 359 | CRDF | Cardiff Oncology, Inc. | 115.54M | -1.74% | 418,955 | 593.00K |
| 360 | CGTX | Cognition Therapeutics, Inc. | 114.35M | -0.02% | 316,624 | - |
| 361 | VRCA | Verrica Pharmaceuticals Inc. | 114.32M | -2.49% | 6,911 | 35.58M |
| 362 | VANI | Vivani Medical, Inc. | 113.43M | -3.60% | 123,458 | - |
| 363 | GNLX | Genelux Corporation | 112.04M | -1.37% | 54,727 | 8.00K |
| 364 | TTRX | Turn Therapeutics Inc. | 109.92M | -0.27% | 1,319 | - |
| 365 | SEER | Seer, Inc. | 109.46M | -0.51% | 337,861 | 16.58M |
| 366 | CBUS | Cibus, Inc. | 109.08M | -4.03% | 92,684 | 3.64M |
| 367 | PEPG | PepGen Inc. | 108.86M | -1.56% | 281,780 | - |
| 368 | PYXS | Pyxis Oncology, Inc. | 107.44M | -2.84% | 231,338 | 13.86M |
| 369 | ONCY | Oncolytics Biotech Inc. | 105.68M | -6.06% | 951,853 | - |
| 370 | NTHI | NeOnc Technologies Holdings, Inc. | 105.62M | -8.03% | 72,744 | 39.99K |
| 371 | KALA | KALA BIO, Inc. | 104.57M | -5.78% | 3,941,065 | - |
| 372 | GUTS | Fractyl Health, Inc. | 104.07M | 0.44% | 844,987 | 3.00K |
| 373 | COYA | Coya Therapeutics, Inc. | 100.16M | -2.95% | 40,630 | 7.95M |
| 374 | ANIX | Anixa Biosciences, Inc. | 99.86M | 0.28% | 93,231 | - |
| 375 | PMN | ProMIS Neurosciences, Inc. | 99.09M | -0.45% | 28,835 | - |
| 376 | NRXP | NRx Pharmaceuticals, Inc. | 98.44M | -1.65% | 533,602 | 1.23M |
| 377 | ALDX | Aldeyra Therapeutics, Inc. | 95.09M | - | 463,363 | - |
| 378 | INO | Inovio Pharmaceuticals, Inc. | 95.05M | -0.85% | 637,352 | 65.34K |
| 379 | NRXS | NeurAxis, Inc. | 89.05M | -4.80% | 74,354 | 3.57M |
| 380 | EXOZ | eXoZymes, Inc. | 87.55M | -2.59% | 959 | -700.00 |
| 381 | RANI | Rani Therapeutics Holdings, Inc. | 85.49M | -3.75% | 232,422 | 1.63M |
| 382 | PTHS | Pelthos Therapeutics Inc. | 83.62M | 0.61% | 27,813 | 16.80M |
| 383 | PYPD | PolyPid Ltd. | 83.11M | -4.91% | 5,619 | - |
| 384 | QTTB | Q32 Bio Inc. | 82.95M | 3.66% | 80,762 | 53.74M |
| 385 | ACET | Adicet Bio, Inc. | 82.22M | -3.55% | 26,282 | - |
| 386 | CSBR | Champions Oncology, Inc. | 81.93M | -1.99% | 8,041 | 57.95M |
| 387 | OKYO | OKYO Pharma Limited | 81.87M | -1.27% | 8,562 | - |
| 388 | SGMO | Sangamo Therapeutics, Inc. | 80.24M | -7.76% | 2,621,157 | 39.55M |
| 389 | LONA | LeonaBio, Inc. | 80.22M | 2.28% | 5,066 | - |
| 390 | GANX | Gain Therapeutics, Inc. | 79.41M | -3.59% | 334,436 | - |
| 391 | ATHE | Alterity Therapeutics Limited | 78.18M | -0.97% | 13,703 | 4.43M |
| 392 | GOSS | Gossamer Bio, Inc. | 78.08M | -4.53% | 5,270,532 | 48.47M |
| 393 | XBIT | XBiotech Inc. | 78.05M | -0.58% | 19,437 | - |
| 394 | ATYR | aTyr Pharma, Inc. | 77.92M | 0.48% | 368,446 | 190.00K |
| 395 | MAIA | MAIA Biotechnology, Inc. | 77.05M | 2.42% | 164,943 | - |
| 396 | PMVP | PMV Pharmaceuticals, Inc. | 76.26M | -0.69% | 99,752 | - |
| 397 | PLRX | Pliant Therapeutics, Inc. | 75.85M | 1.24% | 197,339 | - |
| 398 | FLNA | Filana Therapeutics, Inc. | 75.84M | 0.64% | 147,684 | - |
| 399 | ICCC | ImmuCell Corporation | 75.45M | 1.09% | 5,686 | 27.64M |
| 400 | TCRX | TScan Therapeutics, Inc. | 75.13M | -4.58% | 357,084 | 10.33M |
| 401 | ACRV | Acrivon Therapeutics, Inc. | 73.61M | 1.06% | 415,615 | - |
| 402 | OSTX | OS Therapies Incorporated | 72.73M | -2.26% | 833,335 | - |
| 403 | IBO | Impact BioMedical Inc. | 71.36M | 0.27% | 39,867 | 32.00K |
| 404 | FBIO | Fortress Biotech, Inc. | 71.33M | -2.42% | 158,716 | 63.26M |
| 405 | ACTU | Actuate Therapeutics, Inc. | 69.71M | 3.16% | 86,458 | - |
| 406 | MCRB | Seres Therapeutics, Inc. | 67.87M | -3.28% | 35,460 | 789.00K |
| 407 | MNOV | MediciNova, Inc. | 67.43M | - | 22,869 | 409.66K |
| 408 | ESLA | Estrella Immunopharma, Inc. | 67.41M | -5.95% | 12,044 | - |
| 409 | IMMP | Immutep Limited | 66.75M | -10.26% | 1,803,079 | 5.28M |
| 410 | ANVS | Annovis Bio, Inc. | 65.27M | - | 939,784 | - |
| 411 | BYSI | BeyondSpring Inc. | 64.97M | 1.28% | 1,646 | 1.88M |
| 412 | IMA | ImageneBio, Inc. | 62.86M | -3.60% | 40,037 | 800.00K |
| 413 | PDSB | PDS Biotechnology Corporation | 62.51M | 20.43% | 1,130,272 | - |
| 414 | IBIO | iBio, Inc. | 60.72M | -1.76% | 409,117 | 300.00K |
| 415 | HYFT | MindWalk Holdings Corp. | 60.59M | 5.17% | 67,889 | 20.70M |
| 416 | CING | Cingulate Inc. | 58.49M | -4.37% | 338,440 | - |
| 417 | TIL | Instil Bio, Inc. | 54.80M | -0.62% | 12,751 | - |
| 418 | MGX | Metagenomi Therapeutics, Inc. | 54.36M | -2.36% | 46,931 | 25.21M |
| 419 | KZR | Kezar Life Sciences, Inc. | 54.00M | 0.27% | 2,369 | - |
| 420 | INKT | MiNK Therapeutics, Inc. | 53.97M | -2.44% | 12,465 | - |
| 421 | ENTX | Entera Bio Ltd. | 52.68M | -1.75% | 117,455 | 42.00K |
| 422 | RADX | Radiopharm Theranostics Limited | 50.96M | -3.87% | 4,940 | 10.86M |
| 423 | TELO | Telomir Pharmaceuticals, Inc. | 50.88M | 4.23% | 74,860 | - |
| 424 | NTRB | Nutriband Inc. | 47.53M | 0.51% | 13,951 | 2.28M |
| 425 | HYPD | Hyperion DeFi, Inc. | 47.50M | -5.01% | 141,586 | 813.46K |
| 426 | XLO | Xilio Therapeutics, Inc. | 47.13M | -0.37% | 17,698 | 43.77M |
| 427 | RLYB | Rallybio Corporation | 46.97M | 1.14% | 26,162 | 858.00K |
| 428 | ATOS | Atossa Therapeutics, Inc. | 46.67M | -0.55% | 22,007 | - |
| 429 | DWTX | Dogwood Therapeutics, Inc. | 45.11M | 0.79% | 65,790 | - |
| 430 | MREO | Mereo BioPharma Group plc | 44.58M | -0.32% | 1,005,218 | 500.00K |
| 431 | CUE | Cue Biopharma, Inc. | 43.62M | -25.26% | 635,649 | 27.47M |
| 432 | LITS | Lite Strategy, Inc. | 42.00M | -1.28% | 140,609 | - |
| 433 | LIXT | Lixte Biotechnology Holdings, Inc. | 41.59M | -5.79% | 16,107 | - |
| 434 | PTN | Palatin Technologies, Inc. | 40.76M | -0.84% | 766 | 8.96M |
| 435 | ATRA | Atara Biotherapeutics, Inc. | 39.75M | -2.61% | 13,894 | 120.77M |
| 436 | SNSE | Sensei Biotherapeutics, Inc. | 39.50M | -6.55% | 83,734 | - |
| 437 | PSTV | Plus Therapeutics, Inc. | 39.32M | -4.34% | 77,171 | 5.21M |
| 438 | RNTX | Rein Therapeutics Inc. | 39.25M | -6.04% | 91,593 | - |
| 439 | ALGS | Aligos Therapeutics, Inc. | 39.01M | -1.94% | 44,712 | 2.19M |
| 440 | RNXT | RenovoRx, Inc. | 37.84M | -3.46% | 425,347 | 1.12M |
| 441 | INMB | INmune Bio Inc. | 37.75M | -3.40% | 87,316 | 50.00K |
| 442 | ATNM | Actinium Pharmaceuticals, Inc. | 37.41M | -0.83% | 86,872 | 90.00K |
| 443 | VERU | Veru Inc. | 37.24M | -0.85% | 17,129 | 16.89M |
| 444 | HOWL | Werewolf Therapeutics, Inc. | 35.48M | -12.05% | 695,480 | 1.14M |
| 445 | EVAX | Evaxion A/S | 34.78M | -0.24% | 21,126 | 7.53M |
| 446 | CRVO | CervoMed Inc. | 33.89M | -4.19% | 45,938 | 4.01M |
| 447 | NXTC | NextCure, Inc. | 33.50M | -2.18% | 11,447 | - |
| 448 | PLUR | Pluri Inc. | 33.42M | 2.52% | 140 | 1.34M |
| 449 | SKYE | Skye Bioscience, Inc. | 32.68M | -12.22% | 264,549 | - |
| 450 | GRCE | Grace Therapeutics, Inc. | 32.34M | -3.24% | 437,973 | - |
| 451 | BOLD | Boundless Bio, Inc. | 32.27M | -2.04% | 107,753 | - |
| 452 | DARE | Daré Bioscience, Inc. | 32.18M | -1.34% | 82,174 | 1.03M |
| 453 | IGC | IGC Pharma, Inc. | 30.52M | -3.53% | 598,207 | 1.11M |
| 454 | PLRZ | Polyrizon Ltd. | 30.31M | 2.22% | 59,005 | - |
| 455 | SNTI | Senti Biosciences Holdings, Inc. | 29.89M | -9.45% | 179,595 | 22.00K |
| 456 | CELU | Celularity Inc. | 29.70M | 4.03% | 24,726 | 40.58M |
| 457 | DYAI | Dyadic International, Inc. | 29.61M | -0.91% | 14,503 | 3.09M |
| 458 | TVRD | Tvardi Therapeutics, Inc. | 29.46M | 3.29% | 8,336 | - |
| 459 | BCTX | BriaCell Therapeutics Corp. | 29.18M | -0.50% | 79,782 | - |
| 460 | LSTA | Lisata Therapeutics, Inc. | 28.84M | 2.32% | 7,467 | 170.00K |
| 461 | KYNB | Kyntra Bio, Inc. | 28.57M | 0.43% | 862 | 6.44M |
| 462 | OTLK | Outlook Therapeutics, Inc. | 28.48M | -4.49% | 2,486,970 | 205.70K |
| 463 | TVGN | Tevogen Bio Holdings Inc. | 28.15M | -3.43% | 8,255 | - |
| 464 | NEUP | Neuphoria Therapeutics Inc. | 28.09M | 1.17% | 8,283 | 14.99M |
| 465 | APLM | Apollomics, Inc. | 27.59M | -2.58% | 6,027 | 8.99M |
| 466 | NRSN | NeuroSense Therapeutics Ltd. | 27.22M | 2.60% | 86,127 | - |
| 467 | ABVC | ABVC BioPharma, Inc. | 26.32M | -1.39% | 21,512 | 797.92K |
| 468 | LGVN | Longeveron Inc. | 26.25M | -0.40% | 147,021 | 1.20M |
| 469 | QNTM | Quantum BioPharma Ltd. | 26.07M | 15.73% | 514,399 | - |
| 470 | AEON | AEON Biopharma, Inc. | 26.06M | -0.96% | 29,626 | - |
| 471 | JSPR | Jasper Therapeutics, Inc. | 25.61M | -1.65% | 157,079 | - |
| 472 | BRNS | Barinthus Biotherapeutics plc | 25.40M | -1.29% | 6,468 | 14.97M |
| 473 | NNVC | NanoViricides, Inc. | 24.94M | -7.62% | 388,340 | - |
| 474 | LTRN | Lantern Pharma Inc. | 24.66M | -10.57% | 145,490 | - |
| 475 | TPST | Tempest Therapeutics, Inc. | 24.53M | -0.58% | 100,351 | - |
| 476 | CVM | CEL-SCI Corporation | 24.52M | -7.06% | 68,046 | - |
| 477 | VTGN | Vistagen Therapeutics, Inc. | 23.73M | 4.83% | 296,194 | 789.00K |
| 478 | MRKR | Marker Therapeutics, Inc. | 23.59M | -2.41% | 50,504 | 3.55M |
| 479 | CRIS | Curis, Inc. | 23.27M | 0.07% | 72,672 | 9.44M |
| 480 | OSRH | OSR Holdings, Inc. | 23.02M | -3.98% | 588,496 | 2.91M |
| 481 | SER | Serina Therapeutics, Inc. | 22.29M | 0.56% | 34,524 | 130.00K |
| 482 | LEXX | Lexaria Bioscience Corp. | 21.86M | -7.22% | 75,903 | 368.00K |
| 483 | ALLR | Allarity Therapeutics, Inc. | 21.75M | 0.36% | 52,638 | 320.00K |
| 484 | XCUR | Exicure, Inc. | 21.67M | -4.49% | 8,771 | 500.00K |
| 485 | VYNE | VYNE Therapeutics Inc. | 21.23M | -0.23% | 30,772 | 570.00K |
| 486 | QNCX | Quince Therapeutics, Inc. | 20.05M | -4.65% | 1,069,977 | - |
| 487 | COCP | Cocrystal Pharma, Inc. | 19.58M | 1.43% | 35,733 | - |
| 488 | PASG | Passage Bio, Inc. | 18.41M | 0.53% | 38,702 | - |
| 489 | LPCN | Lipocine Inc. | 18.10M | -4.85% | 115,911 | 1.98M |
| 490 | CVKD | Cadrenal Therapeutics, Inc. | 17.04M | -2.89% | 32,380 | - |
| 491 | KTTA | Pasithea Therapeutics Corp. | 17.01M | -1.17% | 65,105 | - |
| 492 | GNTA | Genenta Science S.p.A. | 16.97M | -2.51% | 11,546 | - |
| 493 | NCEL | NewcelX Ltd. | 16.83M | -4.58% | 24,754 | - |
| 494 | TOVX | Theriva Biologics, Inc. | 16.05M | -1.12% | 1,873,916 | - |
| 495 | ICU | SeaStar Medical Holding Corporation | 15.78M | 3.68% | 23,683 | 1.23M |
| 496 | INAB | IN8bio, Inc. | 15.66M | 1.92% | 28,939 | - |
| 497 | HIND | Vyome Holdings, Inc. | 14.88M | -1.40% | 29,359 | 319.71K |
| 498 | CTXR | Citius Pharmaceuticals, Inc. | 14.64M | -5.34% | 871,706 | 3.94M |
| 499 | PBM | Psyence Biomedical Ltd. | 14.63M | -9.50% | 181,755 | - |
| 500 | HOTH | Hoth Therapeutics, Inc. | 14.29M | -4.21% | 214,356 | - |